colon cancer

Antibody-drug conjugates (ADC), a fast-growing next-generation cancer treatment, have become an investment hotspot due to its potential to become mainstream…

Two Chinese drug developers have signed licensing deals that could yield as much as US$2.5 billion in performance-based payments, underscoring…

HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…